Author:
Zimmermann Mona L. M.,Breedt Lucas C.,Centeno Eduarda G. Z.,Reijneveld Jaap C.,Santos Fernando A. N.,Stam Cornelis J.,van Lingen Marike R.,Schoonheim Menno M.,Hillebrand Arjan,Douw Linda
Abstract
Abstract
Purpose
Glioma is associated with pathologically high (peri)tumoral brain activity, which relates to faster progression. Functional connectivity is disturbed locally and throughout the entire brain, associating with symptomatology. We, therefore, investigated how local activity and network measures relate to better understand how the intricate relationship between the tumor and the rest of the brain may impact disease and symptom progression.
Methods
We obtained magnetoencephalography in 84 de novo glioma patients and 61 matched healthy controls. The offset of the power spectrum, a proxy of neuronal activity, was calculated for 210 cortical regions. We calculated patients’ regional deviations in delta, theta and lower alpha network connectivity as compared to controls, using two network measures: clustering coefficient (local connectivity) and eigenvector centrality (integrative connectivity). We then tested group differences in activity and connectivity between (peri)tumoral, contralateral homologue regions, and the rest of the brain. We also correlated regional offset to connectivity.
Results
As expected, patients’ (peri)tumoral activity was pathologically high, and patients showed higher clustering and lower centrality than controls. At the group-level, regionally high activity related to high clustering in controls and patients alike. However, within-patient analyses revealed negative associations between regional deviations in brain activity and clustering, such that pathologically high activity coincided with low network clustering, while regions with ‘normal’ activity levels showed high network clustering.
Conclusion
Our results indicate that pathological activity and connectivity co-localize in a complex manner in glioma. This insight is relevant to our understanding of disease progression and cognitive symptomatology.
Funder
Koningin Wilhelmina Fonds voor de Nederlandse Kankerbestrijding
Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Branco Weiss Fellowship
Publisher
Springer Science and Business Media LLC